Zhong Yuan Bio-Technology Holdings LtdOTCQB:ZHYBF
- LAST PRICE5.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close5.0000 / 5.0000
- Day Range
- 52 Week Range
- Volume100
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZHYBF |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zhong Yuan Bio-Technology Holdings Ltd | 88.4M | 392.2x | --- |
Cellectar Biosciences Inc | 97.7M | -0.9x | --- |
Spectral Medical Inc | 97.9M | -8.6x | --- |
Hongchang International Co Ltd | 115.5M | -258.8x | --- |
Global Pharmatech Inc | 59.3M | -1.6x | --- |
Odonate Inc | 55.0M | -1,384.3x | --- |
Company Information
Zhong Yuan Bio-Technology Holdings Ltd is an investment holding company principally engaged in the development and sale of health supplements. The Company operates its business through two segments. The Sales of Health Care Supplements segment is engaged in the development and sale of new drugs for neurological disorders, brain disease detection kits, the sale of plant-derived nervonic acid health supplements as well as others. The Company's main products are nervonic acid series supplements, marketed under the 'Muzhiyuan Neuro Enhancer' brand. The Technical Supporting Services segment is engaged in the provision of technical services.
Contact Information
- Headquarters
- Suite 901 Tesbury Centre,, 28 Queen's Road EastBEVERLY HILLS, CA, Hong Kong 00000
- Phone
- ---
- Fax
- ---
Executives
- President, Chief Executive Officer, Company Secretary, Director
- Ting Ting Chang
- Chief Financial Officer, Director
- Fung Ming Pang
- Chief Technical Officer of Bao Feng
- Xianyang Chen
- Chief Marketing Officer of Bao Feng
- Yu Gao
- Independent Non-Executive Director
- Shuo Dong
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $88.4M |
|---|---|
Revenue (TTM) | $2.5M |
Shares Outstanding | 17.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.01 |
Book Value | $-0.02 |
P/E Ratio | 392.2x |
Price/Sales (TTM) | 35.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | 9.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
